Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Discontinuation at 28 or 36 Weeks' Gestation in High-Risk Pregnant Women of Preeclampsia A Randomized Clinical Trial

NCT06111079 is registered in ClinicalTrials.gov with FANG HE as lead sponsor.

NCT NCT06111079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06111079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Discontinuation at 28 or 36 Weeks' Gestation in High-Risk Pregnant Women of Preeclampsia A Randomized Clinical Trial
Lead sponsor
FANG HE
Phase
Phase 3
Overall status
Unknown status
Start date
November 1, 2023
Completion date
December 31, 2024
Enrollment
1,800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perinatal haemorrhage, preeclampsia